Abivax Files September 2024 6-K Report
Ticker: AAVXF · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1956827
| Field | Detail |
|---|---|
| Company | Abivax S.A. (AAVXF) |
| Form Type | 6-K |
| Filed Date | Sep 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Abivax filed its monthly 6-K, confirming 20-F reporting and Paris HQ.
AI Summary
Abivax S.A. filed a Form 6-K on September 26, 2024, reporting for the month of September 2024. The filing indicates that Abivax is a foreign private issuer and will file its annual reports under cover of Form 20-F. The company's principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
Why It Matters
This filing provides routine updates for investors regarding Abivax's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new financial or operational information that would typically impact risk.
Key Players & Entities
- Abivax S.A. (company) — Registrant
- September 2024 (date) — Reporting period
- 20240926 (date) — Filing date
- 7-11 boulevard Haussmann, 75009 Paris, France (location) — Principal executive office address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded, or that they have distributed or are required to distribute to their security holders.
What does it mean that Abivax is a 'foreign private issuer'?
A 'foreign private issuer' is a foreign issuer other than a foreign government. It generally means the company is incorporated outside the U.S. and is not a U.S. resident.
Under which form will Abivax file its annual reports?
Abivax will file its annual reports under cover of Form 20-F.
Where are Abivax's principal executive offices located?
Abivax's principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
What is the Commission File Number for Abivax?
The Commission File Number for Abivax is 001-41842.
Filing Stats: 189 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-09-26 06:05:54
Filing Documents
- f6k_092624.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 14KB
- 0001171843-24-005360.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Abivax SA (Registrant) Date: September 26, 2024 /s/ Marc de Garidel Marc de Garidel Chief Executive Officer